Development of a rapid phenotypic test for HCV protease inhibitors with potential use in clinical decisions
Abstract Approximately 185 million people worldwide are chronically infected with hepatitis C virus (HCV). The first-wave of approved NS3 protease inhibitors (PIs) were Telaprevir and Boceprevir, which are currently discontinued. Simeprevir is a second-wave PI incorporated into the Brazilian hepatit...
সংরক্ষণ করুন:
| প্রধান লেখক: | , , , , , , , |
|---|---|
| বিন্যাস: | Artigo |
| ভাষা: | Inglês |
| প্রকাশিত: |
Sociedade Brasileira de Genética
|
| মালা: | Genetics and Molecular Biology |
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572016000300358&lng=en&tlng=en |
| ট্যাগগুলো: |
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|